All In Biotech

Free tool

FAERS Monitor: Arava

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020905 or its brand name (Arava, Leflunomide). Reports on generic versions are filed under their own applications.

Reports

105,017

Serious

86,607

82% of reports

Hospitalization

29,266

Death reported

9,734

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective37,556
  • rheumatoid arthritis25,571
  • pain20,664
  • arthralgia17,585
  • joint swelling16,083
  • drug intolerance16,075
  • fatigue15,939
  • rash13,880
  • off label use12,440
  • abdominal discomfort12,207
  • alopecia12,125
  • contraindicated product administered12,068
  • arthropathy11,238
  • condition aggravated10,804
  • swelling10,697

Reports by year received

View as table
YearReports
20041,148
20051,086
2006937
20071,312
20081,492
20091,511
20101,455
20111,605
20122,205
20132,685
20142,525
20153,489
20165,125
20176,990
20188,638
201910,706
202014,772
20219,336
20228,136
20235,368
20246,339
20255,339
20262,818

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,949,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contraindicated product administeredSignal12,068132.0129.1945,373
rheumatoid arthritisSignal25,57157.957.21,114,440
arthropathySignal11,23850.549.5436,104
drug intoleranceSignal16,07539.839.1508,904
joint swellingSignal16,08330.630.2401,882
swellingSignal10,69725.725.2226,053
abdominal discomfortSignal12,20715.615.4156,339
alopeciaSignal12,12513.112.9128,487
arthralgiaSignal17,5858.88.7118,783
condition aggravatedSignal10,8047.37.257,919
painSignal20,6646.96.9104,513
rashSignal13,8806.66.564,583
drug ineffectiveSignal37,5565.85.8156,334
fatigueSignal15,9394.24.138,991
off label useSignal12,4402.92.815,611

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.